Corton Capital’s Mesa Laboratories MLAB Stock Holding History

Corton Capital’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,009	Closed	-$261K	–	539
2024 Q3	$261K	Buy	+2,009	New	+$236K	0.13%	249

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Corton Capital's MLAB Position: Q4 2024 in Review

Corton Capital sold out of Mesa Laboratories (MLAB) in Q4 2024, closing a stake of 2,009 shares — an estimated $261K sold.

Corton Capital first reported a position in MLAB in Q3 2024 and held it in 1 quarter. The position peaked at $261K in Q3 2024. 156 funds tracked by Wall St. Rank hold MLAB as of Q4 2024.

Corton Capital reported no remaining Mesa Laboratories position as of Q4 2024 after selling out during the quarter.
Corton Capital sold 2,009 Mesa Laboratories shares in Q4 2024, an estimated $261K.
Corton Capital first reported a position in Mesa Laboratories in Q3 2024 and held it in 1 quarter.
Corton Capital's Mesa Laboratories position peaked at $261K in Q3 2024.
156 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.